Moneycontrol
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Bliss GVS Pharma

BSE: 506197|NSE: BLISSGVS|ISIN: INE416D01022|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Dec 15, 16:00
201.40
3.3 (1.67%)
VOLUME 205,889
LIVE
NSE
Dec 15, 15:54
202.25
5.1 (2.59%)
VOLUME 923,589
Announcements on Bliss GVS

30th-Nov-2017 20:43Source: BSE

Bliss GVS Pharma- Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2017

This is to inform you that the Board Meeting of the Company was held today i.e. November 30, 2017 at the registered office of the Company at 04.00 p.m. The Board considered and approved the following:...

22nd-Nov-2017 23:40Source: BSE

Bliss GVS Pharma- Board Meeting On November 30, 2017

Pursuant to Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board Meeting of the Company...

9th-Nov-2017 10:49Source: BSE

Bliss GVS Pharma- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vibha Gagan Sharma

9th-Nov-2017 10:42Source: BSE

Bliss GVS Pharma- Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gautam Ashra, Vijayaben K Ashra & Antara G Ashra

9th-Nov-2017 10:42Source: NSE

Bliss GVS Pharma Limited

Mr. Gautam Ashra, Mrs. Vijayaben K. Ashra & Ms. Antara G. Ashra has submitted to the Exchange, vide letter dated November 08, 2017 a copy of disclosure under Regulation 10(6) in respect of acquisition...

9th-Nov-2017 09:32Source: NSE

Bliss GVS Pharma Limited

Mr. S.N. Kamath, Mrs. Shruti V. Rao & Dr. Vibha G. Sharma has submitted to the Exchange, vide letter dated November 08, 2017 a copy of disclosure under Regulation 10(6) in respect of acquisition under...

31st-Oct-2017 10:28Source: BSE

Bliss GVS Pharma- Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gautam...

31st-Oct-2017 08:40Source: NSE

Bliss GVS Pharma Limited

Gautam Ashra as submitted to the Exchange, a copy of disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regul...

30th-Oct-2017 18:38Source: BSE

Bliss GVS Pharma- Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011

The Exchange has received the disclosure under Regulation 10(5) in respect of acquisition under Regulation 10(1)(a) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Narsim...

24th-Oct-2017 17:35Source: BSE

Bliss GVS Pharma- Certificate Under Regulation 40(9) & (10) For The Half Year Ended 30Th September, 2017

Certification under Clause 40 (9) of the Listing Regulations for the period 1st April, 2017 to 30th September, 2017.

1 2 3 4 5 Next >>
Quick Links for Bliss GVS Pharma
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.